Skip to main content
Log in

Evaluating Consumer Understanding of Two Patient Instructions for Use Inserts Provided by Manufacturers

  • Advertising and Communication
  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

In addition to the approved package inserts, manufacturers of certain prescription drug products provide approved patient instructions for use inserts to increase patients’ understanding of their medication, aid in its use, and improve compliance. However, the extent to which consumers understand and use the information provided in these inserts is not known. The purpose of this study was to assess these patient instructions for use in inserts supplied in addition to the normal package inserts from the manufacturer.

Ohio consumers between the ages of 18 and 70 were randomly selected for inclusion. Two diverse patient instructions for use from the same product class, Flonase and Nasonex, were evaluated in the study. Sixty-three consumers completed and returned the self-administered questionnaire, which contained 47 questions and used a Likert-type scale with 1 = strongly disagree to 6 = strongly agree. After data analysis was completed, it was found the inserts were not too complex, and were viewed as educational and a reliable source of drug information. Also, consumers felt very confident that they could use the products correctly. In conclusion, these inserts appear to be well understoud, informative, educational, and a useful source of drug information.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gibbs S, Waters WE, George CF. The benefits of prescription information leaflets (1). Br J Clin Pharmac. 1989;27:723–739.

    Article  CAS  Google Scholar 

  2. Svarstad BL, Mount JK. Evaluation of Written Prescription Information Provided in Community Pharmacies, 2001. U.S. Food and Drug Administration. http://www.fda.gov/cder/reports/prescriptionInfo/default.htm. Accessed July 29, 2002.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donald L. Sullivan RPh, PhD.

Additional information

The Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for a maximum of 1 contact hour or 1 continuing education units (CEUs). 286-000-05-402-H04.

If you would like to receive a pharmacy statement of credit. you must review the article. Answer the questions to the posttest on the Post-test and Evaluation Form and submit it to the DIA. Participants must receive a passing score of 80% or better on the post-test in order to receive a pharmacy statement of credit. Pharmacy statements of credit will be mailed within one month of receipt of the Post-test and Evaluation Form. There is no fee to receive your statement of credit.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rollins, B.L., Sullivan, D.L. Evaluating Consumer Understanding of Two Patient Instructions for Use Inserts Provided by Manufacturers. Ther Innov Regul Sci 39, 43–51 (2005). https://doi.org/10.1177/009286150503900106

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150503900106

Key Words

Navigation